Stockreport

NewLink down 8% after bailing on indoximod in melanoma study [Seeking Alpha]

NEWLINK GENETICS  (NLNK) 
Last newlink genetics earnings: 2/28 09:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.linkp.com/investor-relations
PDF NewLink down 8% after bailing on indoximod in melanoma studyNewLink Genetics (NASDAQ:NLNK)announces that it will not proceed to the randomization portion of its Phase 1/ [Read more]